150 related articles for article (PubMed ID: 28076663)
1. Synthesis and Biological Evaluation of Amidinourea and Triazine Congeners as Inhibitors of MDA-MB-231 Human Breast Cancer Cell Proliferation.
Bass R; Jenkinson S; Wright J; Smulders-Srinivasan T; Marshall JC; Castagnolo D
ChemMedChem; 2017 Feb; 12(4):288-291. PubMed ID: 28076663
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring Opening.
Grytsai O; Hamouda-Tekaya N; Botton T; Rocchi S; Benhida R; Ronco C
ChemMedChem; 2024 Feb; 19(3):e202300493. PubMed ID: 38126619
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors.
Zhou X; Lin K; Ma X; Chui WK; Zhou W
Eur J Med Chem; 2017 Jan; 125():1279-1288. PubMed ID: 27886545
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors.
Zhan W; Li Y; Huang W; Zhao Y; Yao Z; Yu S; Yuan S; Jiang F; Yao S; Li S
Bioorg Med Chem; 2012 Jul; 20(14):4323-9. PubMed ID: 22721924
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel 6-hydrazinyl-2,4-bismorpholino pyrimidine and 1,3,5-triazine derivatives as potential antitumor agents.
Zhu W; Liu Y; Zhao Y; Wang H; Tan L; Fan W; Gong P
Arch Pharm (Weinheim); 2012 Oct; 345(10):812-21. PubMed ID: 22707438
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antiproliferative activity evaluation of a series of pyrrolo[2,1-f][1,2,4]triazine derivatives.
Xiang HY; Chen YH; Wang Y; Zhang X; Ding J; Meng LH; Yang CH
Bioorg Med Chem Lett; 2020 Jun; 30(12):127194. PubMed ID: 32317209
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new linear guanidines and macrocyclic amidinourea derivatives endowed with high antifungal activity against Candida spp. and Aspergillus spp.
Manetti F; Castagnolo D; Raffi F; Zizzari AT; Rajamäki S; D'Arezzo S; Visca P; Cona A; Fracasso ME; Doria D; Posteraro B; Sanguinetti M; Fadda G; Botta M
J Med Chem; 2009 Dec; 52(23):7376-9. PubMed ID: 19650630
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.
Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL
Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and in vitro anticancer evaluation of 4,6-diamino-1,3,5-triazine-2-carbohydrazides and -carboxamides.
Kothayer H; Elshanawani AA; Abu Kull ME; El-Sabbagh OI; Shekhar MP; Brancale A; Jones AT; Westwell AD
Bioorg Med Chem Lett; 2013 Dec; 23(24):6886-9. PubMed ID: 24153206
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative activity of novel diaryl ureas possessing a 4H-pyrido[1,2-a]pyrimidin-4-one group.
Yao P; Zhai X; Liu D; Qi BH; Tan HL; Jin YC; Gong P
Arch Pharm (Weinheim); 2010 Jan; 343(1):17-23. PubMed ID: 19927308
[TBL] [Abstract][Full Text] [Related]
14. Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos.
El-Faham A; Farooq M; Almarhoon Z; Alhameed RA; Wadaan MAM; de la Torre BG; Albericio F
Bioorg Chem; 2020 Jan; 94():103397. PubMed ID: 31706684
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of novel 1,2,4-triazine derivatives with antiproliferative activity.
Krauth F; Dahse HM; Rüttinger HH; Frohberg P
Bioorg Med Chem; 2010 Mar; 18(5):1816-21. PubMed ID: 20153202
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4-d][1,2,3]triazine derivatives.
Nasr T; Bondock S; Youns M; Fayad W; Zaghary W
Eur J Med Chem; 2017 Dec; 141():603-614. PubMed ID: 29107422
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiproliferating activity of iron chelators of hydroxyamino-1,3,5-triazine family.
Sun D; Melman G; Letourneau NJ; Hays AM; Melman A
Bioorg Med Chem Lett; 2010 Jan; 20(2):458-60. PubMed ID: 20005708
[TBL] [Abstract][Full Text] [Related]
18. The Antiproliferative and Apoptotic Effect of a Novel Synthesized
Malebari AM; Abd Alhameed R; Almarhoon Z; Farooq M; Wadaan MAM; Sharma A; de la Torre BG; Albericio F; El-Faham A
Molecules; 2021 Feb; 26(4):. PubMed ID: 33671801
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and in vitro antitumor evaluation of novel diaryl ureas derivatives.
Sun M; Wu X; Chen J; Cai J; Cao M; Ji M
Eur J Med Chem; 2010 Jun; 45(6):2299-306. PubMed ID: 20181414
[TBL] [Abstract][Full Text] [Related]
20. Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTOR.
Menear KA; Gomez S; Malagu K; Bailey C; Blackburn K; Cockcroft XL; Ewen S; Fundo A; Le Gall A; Hermann G; Sebastian L; Sunose M; Presnot T; Torode E; Hickson I; Martin NM; Smith GC; Pike KG
Bioorg Med Chem Lett; 2009 Oct; 19(20):5898-901. PubMed ID: 19733066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
